Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.20.2
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 4,610,109      
Beginning balance, amount at Dec. 31, 2018 $ 14,000 $ 48,325,000 $ (55,133,000) $ (6,794,000)
Initial public offering of common stock, shares 2,272,727      
Initial public offering of common stock, amount $ 2,000 22,456,000   22,458,000
Automatic conversion of convertible debt to common stock, shares 1,475,164      
Automatic conversion of convertible debt to common stock, amount $ 2,000 13,791,000   17,793,000
Beneficial conversion feature   7,067,000   7,067,000
Common stock issued for Framerate Acquisition, shares 134,422      
Common stock issued for Framerate Acquisition, amount $ 0 1,000,000   1,000,000
Framerate Earn-Out   454,000   454,000
Stock-based compensation, shares 10,833      
Stock-based compensation, amount $ 0 5,199,000   5,199,000
Stock option and warrant exercises   20,000   20,000
Warrant exercises, shares 66,667      
Warrant exercises, amount $ 0     0
Net loss     (25,991,000) (25,991,000)
Ending balance, shares at Sep. 30, 2019 8,569,922      
Ending balance, amount at Sep. 30, 2019 $ 18,000 98,312,000 (81,124,000) 17,206,000
Beginning balance, shares at Jun. 30, 2019 8,569,922      
Beginning balance, amount at Jun. 30, 2019 $ 18,000 97,598,000 (76,707,000) 20,909,000
Stock-based compensation, amount   714,000   714,000
Net loss     (4,417,000) (4,417,000)
Ending balance, shares at Sep. 30, 2019 8,569,922      
Ending balance, amount at Sep. 30, 2019 $ 18,000 98,312,000 (81,124,000) 17,206,000
Beginning balance, shares at Dec. 31, 2019 8,573,922      
Beginning balance, amount at Dec. 31, 2019 $ 18,000 99,237,000 (85,812,000) 13,443,000
Initial public offering of common stock, shares 1,825,000      
Initial public offering of common stock, amount $ 2,000 5,951,000   5,953,000
Issuance of common stock at $3.50 per share, net of issuance costs, shares 4,988,981      
Issuance of common stock at $3.50 per share, net of issuance costs, amount $ 5,000 8,398,000   8,403,000
Common stock issued for Framerate Acquisition, shares 32,396      
Common stock issued for Framerate Acquisition, amount $ 0 0   0
Stock-based compensation, shares 62,171      
Stock-based compensation, amount $ 0 1,429,000   1,429,000
Stock option and warrant exercises   10,000   10,000
Net loss     (13,992,000) (13,992,000)
Ending balance, shares at Sep. 30, 2020 15,483,010      
Ending balance, amount at Sep. 30, 2020 $ 25,000 115,025,000 (99,804,000) 15,246,000
Beginning balance, shares at Jun. 30, 2020 10,460,696      
Beginning balance, amount at Jun. 30, 2020 $ 20,000 106,237,000 (95,506,000) 10,751,000
Issuance of common stock at $1.85 per share, net of issuance costs, shares 4,988,981      
Issuance of common stock at $1.85 per share, net of issuance costs, amount $ 5,000 8,398,000   8,403,000
Stock-based compensation, shares 33,333      
Stock-based compensation, amount $ 0 380,000   380,000
Stock option and warrant exercises   10,000   10,000
Net loss     (4,298,000) (4,298,000)
Ending balance, shares at Sep. 30, 2020 15,483,010      
Ending balance, amount at Sep. 30, 2020 $ 25,000 $ 115,025,000 $ (99,804,000) $ 15,246,000